Article Text
PDFLetter
Reply to: Hasman A and Holm S. Nicotine conjugate vaccine: is there a right to a smoking future?
Statistics from Altmetric.com
A Hasman and S Holm have evaluated in a recent article in this journal1 the arguments in favour and against the preventive use of an antinicotine vaccine. This has been a timely article in view of the fact that at least three companies …
Footnotes
-
Competing interests: Both authors have an interest in Chilka Ltd, a company involved in the development of vaccines against drugs of abuse.
Read the full text or download the PDF:
Other content recommended for you
- Nicotine conjugate vaccine: is there a right to a smoking future?
- The genetics of tobacco use: methods, findings and policy implications
- Role of smoking in inflammatory bowel disease: implications for therapy
- A research agenda for assessing the potential contribution of genomic medicine to tobacco control
- Nicotine: does it have a role in the treatment of skin disease?
- Reducing the addictiveness of cigarettes
- Double standards and arguments for tobacco regulation
- Menthol's potential effects on nicotine dependence: a tobacco industry perspective
- Innovative approaches to youth tobacco control: introduction and overview
- Nicotine and health